This is a routine director-level Form 144 filing for a modest share amount relative to market cap. The sale is tied to an option exercise, not a distress signal. Monitor for the actual Form 4 filing to confirm execution, but no immediate trading action is warranted.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 10 $27.08entry
- T+1 · 2mo ago +1.00%α +0.14% · $27.35
- T+5 · 2mo ago −0.26%α +0.24% · $27.01
- T+20 · 6w ago +2.77%α +0.65% · $27.83
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Kevin K. Gordon filed a Form 144 notice of intent to sell 11,500 shares of Progyny, Inc. (PGNY) with an approximate market value of $311,859. The sale is planned for execution on or after September 10, 2026, and is associated with a stock option exercise. As a director, this is a routine insider sale and does not carry the same weight as a C-suite disposition. The filing is an advance notice of intent, not a completed sale, and the shares may not ultimately be sold.
Key Facts
- Director Kevin K. Gordon filed a Form 144 to sell 11,500 shares of PGNY.
- The approximate market value of the proposed sale is $311,859.
- The sale is associated with a stock option exercise.
- The filing date is September 10, 2026, with the sale planned for the same day.
- The shares are to be sold through Fidelity Brokerage Services LLC.
Financial Impact
Proposed sale of 11,500 shares valued at approximately $311,859, representing a small fraction of the company's $2.1B market cap.
Risk Factors
- Insider sale could signal reduced conviction if followed by additional filings from other insiders.
- The sale is not yet executed; the insider may choose not to sell.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-006853 |
| Document: 0001959173-26-006853-index.html | 0001959173-26-006853 |
| Document: 0001959173-26-006853.txt | 0001959173-26-006853 |
Track record
26 reports on PGNY
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +6.43% at T+5 after the Nov 4, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers